(5-(Dimethylcarbamoyl)-2-fluorophenyl)boronic acid, 95.0%, 250mg

tert-Butyl (2R)-2-(aminomethyl)-2-ethylazetidine-1-carboxylate, 98+%, 500mg

Methyl 2-methyl-1H-imidazole-5-carboxylate, 95.0%, 250mg

7-Bromochroman, 97.0%, 1g

Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 10g

(S)-2-Acetamido-3-(4-acetoxyphenyl)propanoic acid, 95.0%, 1g

Iohexol (mixture of isomers)>98.0%(HPLC)(N)25g

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetamide, 95.0%, 10g

Cuvettes d'électroporation 850 µl, 10 pièces 10 pièces

(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione, 95.0%, 25g

1,4-Diethynylbenzene>98.0%(GC)1g

(S)-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methanol, 97%, 100mg

2-Fluoro-5-iodotoluene>98.0%(GC)25g